MoneyWorks4Me

Neuland Laboratories - Quaterly Results

01 Aug 2024 Evaluate
The company witnessed a 21.10% growth in the revenue at Rs. 4396.02 millions for the quarter ended June 2024 as compared to Rs. 3629.94 millions during the year-ago period.The Profit  for the quarter ended June 2024 of  Rs. 983.39  millions  grew by 58.04% from Rs. 622.24 millions.Operating profit for the quarter ended June 2024 rose to 1286.33 millions as compared to 993.04 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 4396.02 3629.94 21.10 4396.02 3629.94 21.10 15585.80 11911.98 30.84
Other Income 48.07 20.39 135.75 48.07 20.39 135.75 125.44 97.48 28.68
PBIDT 1286.33 993.04 29.53 1286.33 993.04 29.53 4744.65 2810.56 68.82
Interest 26.71 22.14 20.64 26.71 22.14 20.64 139.97 130.67 7.12
PBDT 1465.88 970.90 50.98 1465.88 970.90 50.98 4604.68 2679.89 71.82
Depreciation 162.79 135.86 19.82 162.79 135.86 19.82 596.99 527.76 13.12
PBT 1303.09 835.04 56.05 1303.09 835.04 56.05 4007.69 2152.13 86.22
TAX 319.70 212.80 50.23 319.70 212.80 50.23 1011.73 520.94 94.21
Deferred Tax 13.89 3.33 317.12 13.89 3.33 317.12 15.87 17.04 -6.87
PAT 983.39 622.24 58.04 983.39 622.24 58.04 2995.96 1631.19 83.67
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 29.26 27.36 6.96 29.26 27.36 6.96 30.44 23.59 29.02
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..